Navigation Links
ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
Date:6/11/2009

Panel of leading biopharma executives will discuss how Earned Value Management can improve control over clinical development costs, payments, and accruals and facilitate compliance with Sarbanes-Oxley at the DIA 45th Annual Meeting in San Diego.

Chicago, IL (PRWEB) June 11, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Kristin Lucas, Senior Director, Clinical Services, will chair a cross-functional panel of clinical finance and operations experts in discussing "Improving Accrual and Contract Management with Earned Value Management" at the DIA 45th Annual Meeting. Held at the San Diego Convention Center, June 21-25, 2009, the meeting will bring together the biggest names from industry, regulatory, and academia to discuss the issues affecting global drug discovery and development.

Given the unprecedented challenges facing biopharma companies, the ability to accurately measure the performance of clinical studies and better manage cost and schedule components is becoming even more critical. Earned Value Management (EVM), a widely accepted practice in many industries, has gained significant momentum in clinical development based on its ability to:

*Accurately calculate accruals based on when work is actually performed
*Quickly determine if studies are on budget by task, provider or resources
*Effectively track project performance and timelines to determine project health
*Facilitate compliance with Sarbanes-Oxley

Lucas brings more than 15 years of experience in the pharmaceutical and biotech industry to the meeting, with extensive experience in clinical trial budgeting and contract management. Before joining ClearTrial, she led the Financ
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
2. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
3. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
4. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
5. Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy
6. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
7. Microsoft Signs Agreement With Merck & Co. Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry
8. Microtest Laboratories is an Industry Leader in ICH Stability Testing
9. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
10. Sugarcane Ethanol Industry Eager to Implement U.S. Renewable Fuel Standard
11. Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNe...ey have filed on November 16th, 2009 Flibanserin i...ed dyskinesia in Parkinson,s,disease for orphan dr...Agency,(EMEA). Levodopa-induced dyskinesia is a co...arkinson,s and a serious burden to some of those,a...
(Date:11/19/2009)... InSound is honored by lates... Newark, CA (PRWEB) November 16, 20... “invisible” hearing aid from InSound ...;s New Award in the Health category.  &n... is designed to reside deep in the hearing canal f...
(Date:11/18/2009)..., Security personnel need to be able to find expl...ct with them. To aid such searches, the National I...support from the Department of Homeland Security, ...Standard Reference Material (SRM) 2905, Trace Part...ratory assay methods, the SRM will be helpful in c...
(Date:11/18/2009)... , Vernier,s experience in data analysis c...(TM) program kits and curricula provide st...n ,, BEAVERTON, Ore., Nov. 18 ...educational science interfaces, sensors, and softw...l manufacturer and distributor of life science res...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
... President and Chief Financial Officer; Richa...UTH SAN FRANCISCO, Calif., Feb. 11 Anesiva,Inc. (... and year-end,financial results and accomplishment...mmercialization plans for FDA-approved Zingo(TM) (...ermal injection system, as well as,clinical develo...
...orp. (OTC Bulletin Board: TKER), a manufacturer an...inhibiting pathogenic bacteria, today,reported tha...oultry,processing application, Tasker Blue, in a n...cessors. The plant will conduct a short test of th...hich it will purchase the,product at a trial price...
...Choices, More Options to Global ...EARCH TRIANGLE PARK, N.C., Feb. 11,/PRNewswire- Fi...ciences,Inc., today announced a technology collabo...cts to the market faster. Terms of the agreement w... business Pioneer Hi-Bred rights to,Precision,s Di...
Other Biology Technology:Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 2Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 3Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 4Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 5Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 6Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 7Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 8Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook 9Tasker Products Installs Scalder Application at New Poultry Processor's Facility 2Tasker Products Installs Scalder Application at New Poultry Processor's Facility 3DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development 2
(Date:11/20/2009)...DC Nov. 20, 2009) Scientists from the Marine Bio...f the Naval Research Laboratory (NRL) organized an...ts on an Arctic expedition to initiate methane hyd... the spatial variation of sediment contribution to...st Guard Cutter Polar Sea as a research platform, ...
(Date:11/20/2009)...st: Toxins in coal-tar-based sealcoats in parking ..., according to a USGS study. PAHs or polycyclic ...n oil, coal and tar deposits, and can have toxic e...ound in house dust; however, the specific sources ...s found that dust from indoor areas near parking l...
(Date:11/20/2009)...s available in German . , In the current on...on , Dr. Stefanie Eyerich and Dr. Kilian Eyerich t...e London and Istituto Dermopatico dell,Immacolata ...t represents a milestone on the way to developing ...es such as psoriasis and allergic reactions and po...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Discovery of new type of immune cells regulating inflammation in chronic diseases 2Statement by American Dietetic Association Supporting Scientifically Valid Informative Restaurant Labeling as Part of Health Reform 48544 1Statement by American Dietetic Association Supporting Scientifically Valid Informative Restaurant Labeling as Part of Health Reform 48544 2FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 1FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 2FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 3FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 4FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 5FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 6FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 7FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 8FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications 4585 9Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 1Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 2Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 3Response Biomedical Corporation Announces Appointment of Vice President Finance 26 Administration and Chief Financial Officer 48538 4
... COLUMBIA, Mo. University of Missouri scientist ...ver see. These creatures are active only at night ...of headwater streams, an oft-overlooked biological...aduate student Bill Peterman, recently published i...mass (total mass of an organism in an area) of the...
... DURHAM, N.H. Kevin Gardner sees green roads righ...ure in this country needs to be re-built, says Gar...sor of civil engineering and director of the Envir...y to re-build the infrastructure the right way wit...igns that protect air, water, land, and human reso...
... Circular markings on creatures such as butterfli...e conspicuous features, not because they mimic the...esearch published today in the journal, Behavioral... Cambridge challenge the 150-year-old theory about...s. , Many animals possess protective markings to...
Other Biology News:Salamanders, headwater streams critical in food chain 2Paving the way for green roads 2Paving the way for green roads 3Zoologists challenge longstanding theory that 'eyespots' mimic the eyes of predators' enemies 2
Cassette, Sal I from Takara Mirus Bio
Custom DNA Primers from Invitrogen
Assay Diluent from BioFX Laboratories, Inc.
...Immunogen: Synthetic peptide derived from the inte...ity: Specific for the internall region of the junc...ontrols: mouse brain homogenates frozen mouse hipp... blotting Immunohistochemistry(froz) Immunofluores...
Biology Products: